|
1
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hinchliffe SR, Rutherford MJ, Crowther MJ,
et al: Should relative survival be used with lung cancer data? Br J
Cancer. 106:1854–1859. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoshida T, Ishii G, Goto K, et al: Solid
predominant histology predicts EGFR tyrosine kinase inhibitor
response in patients with EGFR mutation-positive lung
adenocarcinoma. J Cancer Res Clin Oncol. 139:1691–1700. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brambilla E, Travis WD, Colby TV, et al:
The new World Health Organization classification of lung tumours.
Eur Respir J. 18:1059–1068. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Giaccone G: Oncogenes and antioncogenes in
lung tumorigenesis. Chest. 109:130S–134S. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zajac-Kaye M: Myc oncogene: a key
component in cell cycle regulation and its implication for lung
cancer. Lung Cancer. 34(Suppl 2): S43–S46. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Warner JR and McIntosh KB: How common are
extraribosomal functions of ribosomal proteins? Mol Cell. 34:3–11.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jang CY, Lee JY and Kim J: RpS3, a DNA
repair endonuclease and ribosomal protein, is involved in
apoptosis. FEBS Lett. 560:81–85. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Q, Yang C, Zhou J, et al: Cloning and
characterization of full-length human ribosomal protein L15 cDNA
which was overexpressed in esophageal cancer. Gene. 263:205–209.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Henry JL, Coggin DL and King CR:
High-level expression of the ribosomal protein L19 in human breast
tumors that overexpress erbB-2. Cancer Res. 53:1403–1048. 1993.
|
|
11
|
Zheng SE, Yao Y, Dong Y, et al:
Down-regulation of ribosomal protein L7A in human osteosarcoma. J
Cancer Res Clin Oncol. 135:1025–2031. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang S, Huang J, He J, et al: RPL41, a
small ribosomal peptide deregulated in tumors, is essential for
mitosis and centrosome integrity. Neoplasia. 12:284–293.
2010.PubMed/NCBI
|
|
13
|
Rao S, Lee SY, Gutierrez A, et al:
Inactivation of ribosomal protein L22 promotes transformation by
induction of the stemness factor, Lin28B. Blood. 120:3764–3773.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Novetsky AP, Zighelboim I, Thompson DM Jr,
et al: Frequent mutations in the RPL22 gene and its clinical
and functional implications. Gynecol Oncol. 128:470–474. 2013.
|
|
15
|
Yang M, Sun H, Wang H, et al:
Down-regulation of ribosomal protein L22 in non-small cell lung
cancer. Med Oncol. 30:6462013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rigaut G, Shevchenko A, Rutz B, et al: A
generic protein purification method for protein complex
characterization and proteome exploration. Nat Biotechnol.
17:1030–1032. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Burckstummer T, Bennett KL, Preradovic A,
et al: An efficient tandem affinity purification procedure for
interaction proteomics in mammalian cells. Nat Methods.
3:1013–1019. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen D, Zhang Z, Li M, et al: Ribosomal
protein S7 as a novel modulator of p53-MDM2 interaction: binding to
MDM2, stabilization of p53 protein, and activation of p53 function.
Oncogene. 26:5029–5037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun XX, Wang YG, Xirodimas DP, et al:
Perturbation of 60 S ribosomal biogenesis results in ribosomal
protein L5- and L11-dependent p53 activation. J Biol Chem.
285:25812–25821. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lohrum MA, Ludwig RL, Kubbutat MH, et al:
Regulation of HDM2 activity by the ribosomal protein L11. Cancer
Cell. 3:577–587. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vazquez A, Bond EE, Levine AJ, et al: The
genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev
Drug Discov. 7:979–987. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Westermarck J, Ivaska J and Corthals GL:
Identification of protein interactions involved in cellular
signaling. Mol Cell Proteomics. 2:1752–1763. 2013. View Article : Google Scholar
|
|
23
|
Lavergne JP, Conquet F, Reboud JP, et al:
Role of acidic phosphoproteins in the partial reconstitution of the
active 60 S ribosomal subunit. FEBS Lett. 216:83–88. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shu-Nu C, Lin CH and Lin A: An acidic
amino acid cluster regulates the nucleolar localization and
ribosome assembly of human ribosomal protein L22. FEBS Lett.
484:22–28. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Anderson SJ, Lauritsen JP, Hartman MG, et
al: Ablation of ribosomal protein L22 selectively impairs αβ T cell
development by activation of a p53-dependent checkpoint. Immunity.
26:759–772. 2007.PubMed/NCBI
|
|
26
|
Elia A, Vyas J, Laing KG, et al: Ribosomal
protein L22 inhibits regulation of cellular activities by the
Epstein-Barr virus small RNA EBER-1. Eur J Biochem. 271:1895–1905.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fok V, Mitton-Fry RM, Grech A, et al:
Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA,
recruit human ribosomal protein L22. RNA. 12:872–882. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ni JQ, Liu LP, Hess D, et al:
Drosophila ribosomal proteins are associated with linker
histone H1 and suppress gene transcription. Genes Dev.
20:1959–1973. 2006. View Article : Google Scholar
|
|
29
|
Le S, Sternglanz R and Greider CW:
Identification of two RNA-binding proteins associated with human
telomerase RNA. Mol Biol Cell. 11:999–1010. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stelzl U, Worm U, Lalowski M, et al: A
human protein-protein interaction network: a resource for
annotating the proteome. Cell. 122:957–968. 2005.PubMed/NCBI
|
|
31
|
Gallegos Ruiz MI, Floor K, Rijmen F, et
al: EGFR and K-ras mutation analysis in non-small cell lung cancer:
comparison of paraffin embedded versus frozen specimens. Cell
Oncol. 29:257–264. 2007.PubMed/NCBI
|
|
32
|
Lee NY, Choi HK, Shim JH, et al: The
prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase
to enhance insulin-induced AP-1 activity and cellular
transformation. Carcinogenesis. 30:671–681. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Deisenroth C and Zhang Y: Ribosome
biogenesis surveillance: probing the ribosomal protein-Mdm2-p53
pathway. Oncogene. 29:4253–4260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Komili S, Farny NG, Roth FP, et al:
Functional specificity among ribosomal proteins regulates gene
expression. Cell. 131:557–571. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Poole A, Poore T, Bandhakavi S, et al: A
global view of CK2 function and regulation. Mol Cell Biochem.
274:163–170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Trembley JH, Wang G, Unger G, et al:
Protein kinase CK2 in health and disease: CK2: a key player in
cancer biology. Cell Mol Life Sci. 66:1858–1867. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Meggio F and Pinna LA:
One-thousand-and-one substrates of protein kinase CK2? FASEB J.
17:349–368. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin KY, Tai C, Hsu JC, et al:
Overexpression of nuclear protein kinase CK2 α catalytic subunit
(CK2α) as a poor prognosticator in human colorectal cancer. PLoS
One. 6:e171932011.
|
|
39
|
Siddiqui-Jain A, Drygin D, Streiner N, et
al: CX-4945, an orally bioavailable selective inhibitor of protein
kinase CK2, inhibits prosurvival and angiogenic signaling and
exhibits antitumor efficacy. Cancer Res. 70:10288–10298. 2010.
View Article : Google Scholar
|
|
40
|
Zhao W, Bidwai AP and Glover CV:
Interaction of casein kinase II with ribosomal protein L22 of
Drosophila melanogaster. Biochem Biophys Res Commun.
298:60–66. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Prudent R and Cochet C: New protein kinase
CK2 inhibitors: jumping out of the catalytic box. Chem Biol.
16:112–120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pawson T and Nash P: Protein-protein
interactions define specificity in signal transduction. Genes Dev.
14:1027–1047. 2000.PubMed/NCBI
|
